This pro-fibrotic effect of HIFα inhibition on the HCC TME was further demonstrated by upregulated hepatic mRNA expression of several fibrotic markers, namely α-SMA, MMP-2, MMP-10, MMP-14, MMP-16 and/or TIMP-1. This evidence concerns the gene MMP2 and hepatocellular carcinoma.